Videos

Press Releases

Latest Newsletters

News

Filter on topic
  • Synthesis of minimally important differences to identify patterns for interpreting EORTC QLQ-C30 change scores across nine cancer types

    News,Quality of Life Group

    Synthesis of minimally important differences for interpreting EORTC QLQ-C30 change scores across nine cancer types

  • Annual-Report-2022

    News

    Publication of 2022 EORTC Annual Report

  • Clinical Trials Day 2023

    News

    EORTC is supporting Clinical Trials Day on 20th May

  • EJC publication EORTC 1419 ETERNITY glioblastoma

    Brain Tumour Group,News

    Studying long-term survivors of glioblastoma may pave the way to better treatment

  • European Commission grants

    News

    Three new EORTC clinical trials funded by the EU

  • New results presented at ESTRO 2023

    News

    Important new results from EORTC to be presented at ESTRO 2023

  • HMP Global and EORTC partnership for the 25th annual World Congress on Gastrointestinal Cancer

    Gastrointestinal Tract Cancer Group,News

    HMP Global and EORTC announce partnership for the 25th annual World Congress on Gastrointestinal Cancer

  • First international recommendations on the use of item libraries for patient-reported outcome measurement

    News,Quality of Life Group

    First international recommendations on the use of item libraries for patient-reported outcome measurement

  • FDA Approves KEYTRUDA

    Lung Cancer Group,News

    FDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Patients with Stage IB (T2a ≥4 Centimeters), II, or IIIA Non-Small Cell Lung Cancer (NSCLC)

  • Logos of EORTC and Alliance for Clinical Trials in Oncology and man with mustaches to represent Movember.

    Genito-Urinary Cancers Group,News

    Completion of Patient Recruitment for International TIGER Study